Merck & Co., Inc. (MRK): Dividends Paid
$8.18B
Year ended 2025-12-31
$8.30B
Trailing 12 months to 2026-06-30
+5.3%
3-year compound annual growth
+5.6%
5-year compound annual growth
+4.8%
10-year compound annual growth
| Period ended | Dividends Paid | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.18B | +4.3% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $7.84B | +5.3% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $7.45B | +6.2% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $7.01B | +6.1% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $6.61B | +6.4% | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $6.21B | +9.1% | 2023-02-24, From 2020-01-01 |
| 2019-12-31 | $5.70B | +10.1% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $5.17B | +0.1% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $5.17B | +0.8% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $5.12B | +0.1% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $5.12B | -1.0% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $5.17B | +0.3% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $5.16B | +0.8% | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | $5.12B | +9.1% | 2015-02-27, From 2012-01-01 |
| 2011-12-31 | $4.69B | -0.9% | 2014-02-27, From 2011-01-01 |
| 2010-12-31 | $4.73B | +47.2% | 2013-02-28, From 2010-01-01 |
| 2009-12-31 | $3.21B | -2.0% | 2012-02-28, From 2009-01-01 |
| 2008-12-31 | $3.28B | -0.9% | 2011-02-28, From 2008-01-01 |
| 2007-12-31 | $3.31B | n/a | 2010-03-01, From 2007-01-01 |
Dividends Paid at similar companies
| Company | Year ended | Dividends Paid | Change YoY |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | 2025-12-31 | $8.18B | +4.3% |
| Eli Lilly & Co (LLY) | 2025-12-31 | $5.38B | +15.0% |
| AbbVie Inc. (ABBV) | 2025-12-31 | $11.66B | +5.7% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $5.04B | +3.7% |
| Abbott Laboratories (ABT) | 2025-12-31 | $4.12B | +7.3% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $370.30M | n/a |
| Organon & Co. (OGN) | 2025-12-31 | $88.00M | -70.4% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $159.30M | +4.5% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $19.46M | +0.1% |
Compare MRK, LLY, ABBV, BMY side by side · Screen every company in Pharmaceutical Preparations ↗